Topic: European Medicines Agency
European Medicines Agency to review safety of GlaxoSmithKline's diabetes drug AvandiaThe European Medicines Agency says it will review the safety of the diabetes drug Avandia following research suggesting it is linked to a higher risk of heart problems, strokes and deaths in ...